News and blog

Keeping you up to date with the latest developments in science, policy and health
S1R1C1
 
BlogRethinking HbA1c: genetics, diversity and diabetes diagnosisThursday May 21, 2026Rethinking HbA1c: genetics, diversity and diabetes diagnosis
BlogWhat the UK Biobank data exposure should mean for the Health Data Research ServiceWednesday May 13, 2026Potential fallout from the recent UK Biobank data exposure - and similar cases - highlights that governance cannot be treated as an administrative add on.
BlogHow can genomics inform the public health response to the threat of meningococcal disease?Wednesday April 1, 2026National attention has been gripped by the recent meningitis outbreak.
VacanciesSaturday March 7, 2026We are recruiting for an Administration and Communications Officer
Long-readQuantum computing: The future of healthcare in the UK?Tuesday March 3, 2026Quantum computing, a type of quantum technology, is poised to address pressing challenges in the healthcare sector. Quantum-based discovery techniques could augment and accelerate existing efforts in drug discovery, diagnostics and precision medicine.
BlogHolding the line: why host genomics (and infectious disease) research matters more than everWednesday January 7, 2026One year ago, the PHG Foundation report, Host genomics: lessons for infectious diseases, highlighted the promise of host genomics research for infectious disease. Policy priorities may have changed since then, the evidence has not.
BlogEarly results from the CYP2C19 genotype testing pilot – a landmark moment for personalised stroke careMonday December 22, 2025In a society that spans multiple generations with vastly differing levels of digital literacy and access to resources, one question looms large: who benefits from the digital health transformation, and who risks being left behind?
BlogThe polygenic score paradox: navigating the hope, hype, and hurdles Friday December 19, 2025The successes of polygenic score research are not trivial; they represent real progress and are the reason why researchers, clinicians, and even commercial companies are forging ahead. And yet, for every promising headline, a wave of cautionary evidence is building, urging a more measured and critical perspective.
Past eventExpanding testing of cancer susceptibility genes from the clinic to the population: exploring the evidence gapsThursday December 11, 2025
S2R1C1